What are examples of insulin regimens for non-critical patients who are eating and those who are nothing by mouth (NPO)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Regimens for Non-Critical Hospitalized Patients

For Patients Who Are Eating

An insulin regimen with basal, prandial, and correction components is the preferred treatment for non-critically ill hospitalized patients with good nutritional intake. 1

Dosing Strategy Based on Severity

Mild Hyperglycemia (Blood Glucose <200 mg/dL):

  • Consider low-dose basal insulin (0.1 U/kg/day) with correction doses of rapid-acting insulin before meals 1
  • Alternative: DPP-4 inhibitor with or without low basal insulin dose 1
  • Appropriate for insulin-naive patients or those with low HbA1c on admission 1

Moderate Hyperglycemia (Blood Glucose 201-300 mg/dL):

  • Start basal insulin at 0.2-0.3 U/kg/day 1
  • Add correction doses with rapid-acting insulin before meals 1
  • May combine with oral antidiabetic agents if no contraindications 1

Severe Hyperglycemia (Blood Glucose >300 mg/dL):

  • Implement basal-bolus regimen 1
  • If on home insulin: reduce total daily dose by 20% 1
  • If insulin-naive: start at 0.3 U/kg/day (give half as basal, half as bolus) 1
  • Distribute prandial insulin across three meals 1

Practical Administration Details

Timing of Insulin Injections:

  • Insulin injections should align with meals 1
  • Perform point-of-care glucose testing immediately before meals 1
  • If oral intake is poor, administer prandial insulin immediately after the patient eats, with the dose adjusted for actual carbohydrate consumption 1

Glucose Monitoring:

  • Perform bedside glucose monitoring before meals for eating patients 1

What to Avoid

Sliding scale insulin as the sole treatment is strongly discouraged 1

  • Basal-bolus treatment improved glycemic control and reduced hospital complications compared to sliding scale regimens 1

Premixed insulin regimens are not routinely recommended for in-hospital use 1

  • Associated with significantly increased hypoglycemia compared to basal-bolus therapy 1

For Patients Who Are NPO (Nothing By Mouth)

Basal insulin, or a basal plus bolus correction regimen, is the preferred treatment for non-critically ill hospitalized patients with poor oral intake or those who are NPO. 1

Dosing Strategy

Starting Dose:

  • Basal insulin at 0.2 U/kg/day 1
  • For patients at high risk of hypoglycemia (frail, elderly, acute kidney injury), reduce starting dose to 0.15 U/kg/day 1

Correction Insulin:

  • Add correction doses with rapid-acting insulin every 4-6 hours as needed 1
  • Do not use rapid- or short-acting insulin at bedtime 2

Glucose Monitoring

For NPO patients, glucose monitoring is advised every 4-6 hours 1

Special Considerations for NPO Patients

Withhold prandial insulin if poor oral intake 1

  • Continue basal insulin to prevent metabolic decompensation 3
  • Consider reducing basal dose to 60-80% of usual dose for patients with minimal intake 3

Continuous Enteral/Parenteral Nutrition:

  • Basal insulin or basal plus correction regimen remains appropriate 1
  • For continuous tube feedings: consider premixed 70/30 insulin every 8 hours at total daily dose of 0.6-1.0 U/kg divided into three doses 2

Common Pitfalls to Avoid

Do not rely solely on correction insulin without basal coverage 3

  • This leads to inadequate glycemic control and metabolic instability 3

Monitor for hypoglycemia, especially overnight 3

  • Have hypoglycemia treatment protocol in place (15g fast-acting carbohydrate for conscious patients, intravenous glucose for NPO patients) 3

Reassess insulin requirements daily 3

  • As nutritional status changes, insulin needs will change 3
  • Consider further basal dose reduction if blood glucose consistently <100 mg/dL 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Insulin management of diabetic patients on general medical and surgical floors.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2006

Guideline

Insulin Management for Post-BMT Patients with Mucositis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.